IMPACT OF PHARMACOGENOMICS ON PHARMACOKINETIC OF BETA BLOCKERS
No Thumbnail Available
Files
Date
2024-07-29
Journal Title
Journal ISSN
Volume Title
Publisher
P.C. Publishing House», United Kingdom
Abstract
Beta adrenergic blockers (β‐blockers) antagonize beta-1, beta-2 adrenergic receptors, and have been widely used for cardiovascular therapy, as well as treatment of disorders such as anxiety, thyrotoxicosis and glaucoma.
Description
Keywords
Beta adrenergic blockers, cardiovascular therapy, treatment
Citation
Zolotaikina , M., Fedorytenko , R., Kurmanska , L., & Kirkilevska , L. (2024). IMPACT OF PHARMACOGENOMICS ON PHARMACOKINETIC OF BETA BLOCKERS. Collection of Scientific Papers «ΛΌГOΣ», (July 19, 2024; Boston, USA), 275–276. https://doi.org/10.36074/logos-19.07.2024.054